A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Acerta Pharma BV
Roswell Park Cancer Institute
City of Hope Medical Center
Karyopharm Therapeutics Inc
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Eli Lilly and Company
Roswell Park Cancer Institute
Mayo Clinic
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Mayo Clinic
Fred Hutchinson Cancer Center
Takeda
Barbara Ann Karmanos Cancer Institute
Yale University
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Amgen
Mayo Clinic
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
Northside Hospital, Inc.
Vanderbilt-Ingram Cancer Center
Northside Hospital, Inc.